Related Experiment Video
Updated: Nov 16, 2025

09:57
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
3.1K
Solving Unmet Needs With Innovative Pediatric Medical Devices
IEEE Pulse
|February 19, 2021
Summary
Few life-saving medical devices are approved for pediatric patients, especially infants and neonates. Adult devices are often modified, but these solutions may not meet children
Area of Science:
- Biomedical Engineering
- Pediatric Medicine
- Regulatory Science
Background:
- Class III life-saving devices approved by the U.S. Food and Drug Administration (FDA) are rarely designated for pediatric use, with only 24% approved in the last decade.
- The majority of approved pediatric devices are for older children (over 12 years), with less than 4% specifically labeled for infants and toddlers (0-2 years).
- Neonatal patients face an even greater scarcity of approved medical devices.
Purpose of the Study:
- To highlight the critical gap in life-saving medical device availability for pediatric and neonatal populations.
- To underscore the challenges and limitations of using repurposed adult devices for young patients.
- To advocate for the development of novel medical devices tailored to the unique physiological needs of children.
Main Methods:
- Analysis of FDA approval data for Class III life-saving medical devices over the past decade.
- Categorization of approved devices based on patient age group (pediatric vs. adult, and sub-categories within pediatrics).
- Review of current clinical practices involving the adaptation of adult devices for pediatric use.
Main Results:
- A significant underrepresentation of pediatric-use medical devices among FDA-approved Class III devices.
- A pronounced lack of devices specifically designed and approved for the youngest pediatric age groups (0-2 years) and neonates.
- Prevalence of the use of modified adult medical devices as a workaround for pediatric and neonatal care.
Conclusions:
- There is an urgent unmet need for FDA-approved, life-saving medical devices specifically designed for pediatric and neonatal patients.
- Repurposing adult devices presents significant limitations and potential risks due to differences in anatomy, physiology, and growth patterns.
- Further research and development are crucial to create innovative medical technologies that address the unique requirements of young patients.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
102
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
102
Pharmacokinetics in Pediatric Patients: Drug Metabolism
89
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
100
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
100
Pharmacokinetics in Pediatric Patients: Drug Distribution
120
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
120

